Skip to content
TFS TFS HealthScience | Contract Research Organization | Global Resourcing Provider | CRO
Request a proposal

Dermatology

Therapeutic expertise Dermatology

Over 25 years of specialized dermatology clinical trial expertise

Dermatology development demands deep therapeutic expertise. Whether evaluating inflammatory skin diseases, rare dermatologic conditions, skin cancers, or aesthetic interventions, accurate and consistent endpoint assessment is essential. Our senior dermatologists provide strategic medical guidance throughout development, helping sponsors generate robust, interpretable data and accelerate informed development decisions.
Talk to our dermatology team

+400

Completed trials

+8,000

Investigator sites across 30+ countries

+85K

Patients enrolled

Dermatology expertise across every phase and therapy type

Our clinical trial expertise spans all phases, from first-in-human and proof-of-concept through Phase II to IV and post-marketing research. We support topical and systemic therapies, including small molecules, biologics, immunomodulators, advanced therapies, medical devices, combination products and cosmetic interventions.

From novel oral immunomodulators and precision biologics to cell and regenerative therapies, we optimize protocol design, endpoint strategy, safety oversight and regulatory planning to generate robust, interpretable data for confident development decisions.

Inflammatory and autoimmune skin Diseases
Atopic Dermatitis · Psoriasis · Hidradenitis Suppurativa · Prurigo Nodularis · Acne Vulgaris · Systemic Sclerosis

Skin oncology and precancerous conditions
Actinic Keratosis · Basal Cell Nevus syndrome · Melanoma

Wound care and skin repair
Venous Leg Ulcer · Diabetic foot ulcers · Burns · Scarring

Rare diseases
Netherton syndrome · Palmoplantar Pustulosis · Pyoderma Gangrenosum

Aesthetic dermatology
Wrinkles · Cellulite · Facial volume loss · Skin rejuvenation · Collagen studies

Rheumatology & allergy
Rheumatoid arthritis · Psoriatic arthritis · Axial Spondylarthritis Lupus · Allergic rhinitis

Elvira Szijártó

Medical Director, Dermatology

“Dermatology trials face unique hurdles, from managing placebo responses; assessment variability, and diverse patient populations to precise endpoint evaluation. Embedding specialized medical oversight early protects data integrity and keeps study timelines on track.”

Senior dermatologists and project directors embedded in your trial to accelerate site setup, standardize endpoint assessment and secure clean data.

Know your team

How we secure your clinical pathway

Clinical continuum

Built-in flexibility, from a single CRA to full global trials.

Strategic resourcing, FSP and full-service clinical development, working as one team. Scale capacity across 40 countries, eliminating vendor handoffs while preserving protocol knowledge in the room the whole way through.

Therapeutic depth

Fast decisions through specialized clinical depth.

We restrict our focus to five complex therapeutic areas. Our specialized leads theyhold direct decision-making authority, fast-tracking approvals and solving site bottlenecks with scientific authority.

Teams that stay

True peers, driven by scientific urgency.

TFS holds an 88% retention rate, 8 points above the industry average. That means the senior scientific peer who joins your study is still there at database lock.

Trial security

Risk flagged early. Execution made visible.

Rooted in our Swedish heritage, we bring disciplined methodology and transparent communication to every study. We deliver real-time data integrity, flag protocol issues before they cost you time, and maintain regulatory compliance at every milestone.

Medical and operational
dermatology leadership

Veronika Kunert

Vice President, Head of Dermatology

Maciej Borkowski

Project Management Director, Dermatology

Elvira Szijártó

Medical Director, Dermatology

One team, whether you need a single specialist or a full trial.

Clinical development

Access specialized clinical experts who integrate directly into your internal teams, matching your operational demands as they shift.
— Rapid deployment of validated
clinical professionals.

— Flexible capacity management 
tailored to pipeline shifts.
Phase I to III Phase IV & RWE

Strategic solutions

We embed life sciences expertise wherever your programme needs it: a single expert consultant, a dedicated FSP team, a hybrid model or a fully managed function. Every option draws on 60,000+ active professional profiles and runs on one continuum, with built-in flexibility, trial security and senior teams that stay from day zero.
— Expert consultants matched to your study, on average within five days.

— Dedicated FSP teams, line-managed by TFS and working to your SOPs.

— Hybrid models that combine FSP and full service under one governance.

— Managed functions we run for you, from oversight to systems.
Explore solutions

End-to-end delivery

Full-service trial execution, backed by therapeutic depth and teams that stay.
— Full-lifecycle protocol management 
from design to database lock.

— Scientific leadership across 5 specialized 
therapeutic areas.

— Stable project teams ensuring continuous 
data quality and safety.
Explore solution

Quality Management

Three services. One independent quality function, standalone or embedded across your clinical portfolio.
— Audit & programme management: risk-based GxP audits to detect risks early and drive continuous improvement.

— Inspection readiness: targeted assessments, mock inspections and SME preparation for regulatory scrutiny.

— Quality oversight: ICH E6(R3)- and ICH E8(R1)-aligned oversight across studies and vendors.
Explore solution

Securing the path for sponsors’ science.

View all

The resourcing decision : Full-service, FSP or specialist. Which one actually fits your programme?

Read case study

Juneteenth and the next chapter of medicine

Read case study

This Pride Month see the life behind every number

Read case study

Triumph Over Turbulence: TFS Helps Navigate the Stormy Seas of Recruitment and Safety

Read case study

Updates to keep your trials
moving forward.

News VERIGRAFT and TFS HealthScience partner on pivotal Phase II/III trial of personalized tissue-engineered vein for chronic venous insufficiency
Read news
News Our 2025 sustainability year in review: the highlights
Read news
News Europe's clinical development landscape: does the EU hold a busted flush or a full house?
Read news
News Expanding the Frontiers of Neuroscience: TFS Strengthens Its Gene Therapy Portfolio in Neurodegenerative Diseases
Read news
View all

Clinical operations & outsourcing FAQs.

What clinical outsourcing models does TFS provide?
We deliver three modular frameworks under a single contract: Strategic Resourcing, Functional Service Provider (FSP), and Full-Service Trials. This model elasticity allows you to scale clinical capacity fluidly as your pipeline demands, eliminating vendor handoffs.

What is the geographic footprint and reach of TFS?
Founded in Lund, Sweden, we operate as a global CRO with active regulatory and clinical reach across 40 countries. We combine comprehensive multi-region execution with specialized infrastructure and investigator networks across Europe and the Nordics.

How does TFS maintain clinical study continuity?
We maintain an industry-leading CRA turnover rate of 14%, significantly outperforming the 20% sector average. This team stability ensures consistent protocol knowledge, reduces management burden and protects your data integrity.

Which therapeutic areas does TFS specialize in?
We concentrate our medical, clinical, and regulatory capabilities exclusively within five core areas: Dermatology, Internal Medicine, Neuroscience, Oncology and Ophthalmology, backed by a track record of 1,800+ completed trials.